United States · FDA National Drug Code directory
AZELASTINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-611_cb0aca6d-ff9c-4239-8681-d212a6764ba9
- Product NDC
- 72603-611
- Form
- SPRAY, METERED
- Composition / generic term
- AZELASTINE HYDROCHLORIDE
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250701
- Source listing expiry
- 20261231
Source-listed ingredients
- AZELASTINE HYDROCHLORIDE — 137 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, SPRAY in 1 CARTON (72603-611-01) / 200 SPRAY, METERED in 1 BOTTLE, SPRAY · 72603-611-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →